The biotechnology company said a potential prostate cancer drug failed to meet treatment goals in a key study.
News
- United Airlines, Myovant fall; FitBit, Beyond Meat rise
- Study: Childhood chemo alters heart's caretaker cells
The University of Texas Health Science Center at San Antonio, also ... health professions and graduate biomedical sciences have graduated more ...
- bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc., a privately held biotech company, today announced Martin Tammemägi, PhD, ...
- Diageo, Cleveland-Cliffs rise; Aquestive, Inovio fall
The biotechnology company is delaying the start of a key study for a potential COVID-19 vaccine. Devon Energy Corp., up 98 cents to $9.80. The oil and ...
- GILLIAN ANN FREEMAN
She was a member of the Southwest Foundation Forum, the San Antonio ... Donations in memory of Gillian may be made to the Texas Biomedical ...